PRCT Insider Trading

Insider Ownership Percentage: 17.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $62,839,018.02

PROCEPT BioRobotics Insider Trading History Chart

This chart shows the insider buying and selling history at PROCEPT BioRobotics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40M-$20M$0$20M$40MTotal Insider BuyingTotal Insider Selling

PROCEPT BioRobotics Share Price & Price History

Current Price: $53.03
Price Change: Price Increase of +0.22 (0.42%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for PRCT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$53.03Closing price on 04/20/25:

SEC Filings (Institutional Ownership Changes) for PROCEPT BioRobotics (NASDAQ:PRCT)

89.46% of PROCEPT BioRobotics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PRCT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.87Mbought$27ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M$0$200MTotal InflowsTotal Outflows
PROCEPT BioRobotics logo
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More on PROCEPT BioRobotics

Today's Range

Now: $53.03
Low: $52.13
High: $53.19

50 Day Range

MA: $59.16
Low: $48.82
High: $69.27

52 Week Range

Now: $53.03
Low: $47.04
High: $103.81

Volume

868,416 shs

Average Volume

782,183 shs

Market Capitalization

$2.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of PROCEPT BioRobotics?

PROCEPT BioRobotics' top insider investors include:
  1. Frederic H Moll (Director)
  2. Antal Rohit Desai (Director)
  3. Reza Zadno (CEO)
  4. Morgan Colby Wood (Director)
  5. Kevin Waters (CFO)
  6. Hisham Shiblaq (EVP)
  7. Alaleh Nouri (EVP)
  8. Thomas M Krummel (Director)
Learn More about top insider investors at PROCEPT BioRobotics.

Who are the major institutional investors of PROCEPT BioRobotics?

PROCEPT BioRobotics' top institutional investors include:
  1. Chicago Capital LLC — 0.77%
  2. Rhumbline Advisers — 0.12%
  3. Enclave Advisors LLC — 0.05%
  4. Hennion & Walsh Asset Management Inc. — 0.02%
  5. GAMMA Investing LLC — 0.01%
  6. Sentry Investment Management LLC — 0.01%
Learn More about top institutional investors of PROCEPT BioRobotics stock.

Which major investors are selling PROCEPT BioRobotics stock?

During the previous quarter, PRCT stock was sold by these institutional investors:
  1. Enclave Advisors LLC
In the last year, company insiders that have sold PROCEPT BioRobotics company stock include:
  1. Frederic H Moll (Director)
  2. Antal Rohit Desai (Director)
  3. Reza Zadno (CEO)
  4. Morgan Colby Wood (Director)
  5. Kevin Waters (CFO)
  6. Hisham Shiblaq (EVP)
Learn More investors selling PROCEPT BioRobotics stock.

Which major investors are buying PROCEPT BioRobotics stock?

During the last quarter, PRCT stock was bought by institutional investors including:
  1. Chicago Capital LLC
  2. GAMMA Investing LLC
  3. Rhumbline Advisers
  4. Sentry Investment Management LLC
  5. Hennion & Walsh Asset Management Inc.